These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6452952)

  • 1. BCG-induced chronic pulmonary inflammation and splenomegaly in mice: suppression of PHA-induced proliferation, delayed hypersensitivity to sheep erythrocytes, and chronic pulmonary inflammation by soluble factors from adherent spleen cells.
    Allen EM; Sternick JL; Schrier DJ; Moore VL
    Cell Immunol; 1981 Feb; 58(1):61-71. PubMed ID: 6452952
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic basis of BCG-induced suppression of delayed hypersensitivity.
    Schrier DJ; Sternick JL; Allen EM; Moore VL
    Nature; 1981 Jan; 289(5796):405-7. PubMed ID: 6780914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strain difference in delayed-type hypersensitivity to BCG in mice: role of splenic adherent cells in the primary immune response.
    Nakamura RM; Tanaka H; Tokunaga T
    Immunology; 1982 Dec; 47(4):729-31. PubMed ID: 6216204
    [No Abstract]   [Full Text] [Related]  

  • 4. Suppression of BCG cell wall-induced delayed-type hypersensitivity by pretreatment with killed BCG: induction of nonspecific suppressor T cells by the adjuvant portion (MDP) and of specific suppressor T cells by the antigen portion (TAP).
    Kato K; Yamamoto K; Kimura T; Azuma I; Askenase PW
    J Immunol; 1984 Jun; 132(6):2790-5. PubMed ID: 6202761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active suppression masks an underlying enhancement of antibody production in vitro by spleen cells from BCG-infected mice.
    Brown CA; Brown IN; Sljivić VS
    Immunology; 1980 Jul; 40(3):303-9. PubMed ID: 6448801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetic control of delayed-type hypersensitivity to BCG in mice and the suppressor T cells].
    Nakamura RM
    Kekkaku; 1982 Oct; 57(10):557-60. PubMed ID: 6219238
    [No Abstract]   [Full Text] [Related]  

  • 7. Non-specific immunosuppression by Cryptococcus neoformans infection.
    Blackstock R; Hall NK
    Mycopathologia; 1984 Apr; 86(1):35-43. PubMed ID: 6234468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-specific suppression of delayed-type hypersensitivity by intrathymic injection of killed bacteria.
    Kato K; Yamamoto K
    Thymus; 1984; 6(1-2):79-87. PubMed ID: 6205480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fraction of spleen cells responsible for suppression of cellular immune response to SRBC in mice treated with outer membrane proteins of Shigella.
    Czarny A; Witkowska D; Mulczyk M
    Arch Immunol Ther Exp (Warsz); 1992; 40(2):135-7. PubMed ID: 1299172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective suppression of granuloma formation and delayed hypersensitivity in rabbits.
    Schroff RW; Heise ER; Myrvik QN; Shannon BT
    Infect Immun; 1980 Apr; 28(1):269-76. PubMed ID: 6991441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressor T-cells in BCG-infected mice.
    Collins FM; Watson SR
    Infect Immun; 1979 Aug; 25(2):491-6. PubMed ID: 158567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of BCG cell wall induced delayed-type hypersensitivity by BCG pre-treatment. I. Induction of adherent suppressor cells by live BCG injection and their characterization.
    Kato K; Yamamoto KI; Kakinuma M; Ishihara C; Azuma I
    Immunology; 1981 Feb; 42(2):259-66. PubMed ID: 6450731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCG-induced suppressor T cells optimal conditions for in vitro induction and mode of action.
    Mustafa AS; Godal T
    Clin Exp Immunol; 1985 Dec; 62(3):474-81. PubMed ID: 2935339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of atypical mycobacterial infection on the cell-mediated immunity induced by Mycobacterium bovis BCG in mice. II. Suppression of protective immunity].
    Nakamura RM
    Kekkaku; 1993 May; 68(5):361-5. PubMed ID: 8331880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of pretreatment of mice with BCG cell walls in saline on subsequent vaccination with BCG oil droplet vaccine.
    Meyer TJ; Anacker RL; Ribi E
    Cell Immunol; 1974 Oct; 14(1):52-65. PubMed ID: 4219589
    [No Abstract]   [Full Text] [Related]  

  • 16. Suppression of BCG granuloma formation in mice by sensitized splenic lymphocytes.
    Kyuwa S; Fujiwara K; Ueda K
    Jpn J Exp Med; 1983 Feb; 53(1):69-72. PubMed ID: 6224036
    [No Abstract]   [Full Text] [Related]  

  • 17. A stable form of delayed-type hypersensitivity.
    Lagrange PH; Mackaness GB
    J Exp Med; 1975 Jan; 141(1):82-96. PubMed ID: 1090700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor bearer T cells suppress BCG-potentiated antitumor responses. I. Requirements for their effect.
    Hawrylko E
    Cell Immunol; 1982 Jan; 66(1):121-38. PubMed ID: 6211241
    [No Abstract]   [Full Text] [Related]  

  • 19. Induction and Ly phenotype of suppressor T cells in mice during primary infection with dengue virus.
    Wong PY; Devi S; McKenzie IF; Yap KL; Pang T
    Immunology; 1984 Jan; 51(1):51-6. PubMed ID: 6228519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of humoral immune responses. I. Potentiating influence of purified protein derivative on the invitro immune response of spleen cells sensitized to Mycobacterium bovis and Mycobacterium avium.
    Muscoplat CC; Setcavage TM; Thoen CO; Kim YB
    Int Arch Allergy Appl Immunol; 1976; 52(1-4):266-72. PubMed ID: 797671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.